Boston Scientific Gets $750 Millon for Surgery Businesses


Boston Scientific (NYSE: BSX) announced it has sold its cardiac surgery and vascular surgery businesses to the Getinge Group for $750 million in cash. The Natick, MA-based firm first said it would sell the divisions back in August.

By posting a comment, you agree to our terms and conditions.